Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 1:06 AM
NCT ID:
NCT02906293
Eligibility Criteria:
Inclusion Criteria:
* Healthy adults aged 18 to 65 years
* Able to provide consent
Exclusion Criteria:
* Age younger than 18 or older than 65 years
* Unable to provide consent
* Vegetarian or vegan
* Pregnant
* Prior intestinal surgery
* Recent gastroenteritis, diverticulitis or stool infection within past 3 months
* Diagnosis of irritable bowel syndrome
* Diagnosis of inflammatory bowel disorder (Crohn's disease, ulcerative colitis, indeterminate colitis, microscopic colitis, gastritis or enterocolitis).
* Diagnosis of a malabsorption disorder: Celiac disease, protein losing enteropathy, pancreatic insufficiency, etc.
* Diagnosis of autoimmune disorder: diabetes mellitus, scleroderma, undifferentiated connective tissue disorder, etc.
* Diagnosis of motility disorder: achalasia, esophageal spasm, outlet obstruction, gastroparesis, chronic constipation, etc.
* History of acute pancreatitis within past 3 months
* History of GI malignancy (stomach, small or large intestine, pancreatic, neuroendocrine tumor, etc.)
* Current or recent treatment with chemotherapy within past 3 months
* History of radiation treatment
* Current or recent use (within past month) of medications that either promote or decrease motility: opioids, cholinergic agonists, opioid antagonists, anti-diarrheals, pro-kinetic medications (e.g., metoclopramide, domperidone, erythromycin), etc.
* Antibiotic use within 3 months
* Diabetes mellitus with HgA1C \>6.0
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02906293
Study Brief:
Protocol Section:
NCT02906293